Bavarian Nordic A/s

University of Nebraska

Gsf-Forschungszentrum Fur Umwelt Und Gesundheit, Gmbh

Matthias Löhr

Walter Henry Günzburg

Robert Saller

Brian Salmons

Surinder K Batra

Grish Chandra Varshney

Randall E Brand

Peter Karle

Grit Faulmann

Peter Müller

Jöerg Ringel

The invention relates to an injection device containing a hollow needle (), a cutting needle that can be inserted into the hollow needle and that has a cutting tip projecting from the front end of the hollow needle, a catheter () that replaces said cutting needle and that can be inserted approximately up to its front end into the hollow needle (), said catheter having a receiving chamber () for a substance in the form of a capsule on its distal end, in addition to a mandrin () that can be inserted into the catheter () and which can be placed in a position defining a receiving chamber () filled with capsules () on the distal end of said catheter, wherein the capsules () contained in the receiving chamber () of the inserted catheter () are released without exerting any pressure in the target area of the body () once the injection device has been arranged in a target area of a body () by relatively pulling back both the catheter () and the hollow needle () in relation to the mandrin () and by then withdrawing the mandrin (). Preferably, the catheter () contains a removable sieve () on its frond end.

Injection device and method for injecting capsules

Methods are provided for the diagnosis of pancreatic cancer.

MUCIN 4 expression as a marker for pancreatic cancer

The present invention relates to capsules encapsulating cytochrome P450 producing cells and cytochrome P450 producing retroviral packaging cells. Furthermore, the present invention relates to the treatment of cancer or any other relevant disease with said capsules and to the use of said capsules for the preparation of a pharmaceutical composition for said treatment.

Encapsulated cells producing cytochrome P450

Growing community of inventors

Weinheim, Germany

Matthias Löhr